250 related articles for article (PubMed ID: 21441033)
1. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
6. 9-Arylpurines as a novel class of enterovirus inhibitors.
Aguado L; Thibaut HJ; Priego EM; Jimeno ML; Camarasa MJ; Neyts J; Pérez-Pérez MJ
J Med Chem; 2010 Jan; 53(1):316-24. PubMed ID: 19924996
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
[TBL] [Abstract][Full Text] [Related]
9. Novel benzimidazo[2,1-c][1,4]thiazinone derivatives with potent activity against HSV-1.
Galal SA; El-Naem SI; El-Nezhawy AO; Ali MA; El-Diwani HI
Arch Pharm (Weinheim); 2011 Apr; 344(4):255-63. PubMed ID: 21469175
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents.
Tonelli M; Novelli F; Tasso B; Vazzana I; Sparatore A; Boido V; Sparatore F; La Colla P; Sanna G; Giliberti G; Busonera B; Farci P; Ibba C; Loddo R
Bioorg Med Chem; 2014 Sep; 22(17):4893-909. PubMed ID: 25082514
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives.
Castelli M; Malagoli M; Lupo L; Riccomi TR; Casolari C; Cermelli C; Zanca A; Baggio G
Pharmacol Toxicol; 2001 Feb; 88(2):67-74. PubMed ID: 11169164
[TBL] [Abstract][Full Text] [Related]
12. Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles.
De Palma AM; Heggermont W; Leyssen P; Pürstinger G; Wimmer E; De Clercq E; Rao A; Monforte AM; Chimirri A; Neyts J
Biochem Biophys Res Commun; 2007 Feb; 353(3):628-32. PubMed ID: 17194441
[TBL] [Abstract][Full Text] [Related]
13. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hřebabecký H; Dejmek M; Dračínský M; Leyssen P; Neyts J; Mertlíková-Kaiserová H; Nencka R
Bioorg Med Chem Lett; 2011 Jul; 21(14):4271-5. PubMed ID: 21684160
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt's lymphoma promotion.
Ramla MM; Omar MA; Tokuda H; El-Diwani HI
Bioorg Med Chem; 2007 Oct; 15(19):6489-96. PubMed ID: 17643992
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
[TBL] [Abstract][Full Text] [Related]
17. Antirhino/enteroviral vinylacetylene benzimidazoles: a study of their activity and oral plasma levels in mice.
Tebbe MJ; Spitzer WA; Victor F; Miller SC; Lee CC; Sattelberg TR; McKinney E; Tang JC
J Med Chem; 1997 Nov; 40(24):3937-46. PubMed ID: 9397174
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiviral and antiproliferative activity of some N-benzenesulphonyl-2(2- or 3-pyridylethyl)-benzimidazoles.
Garuti L; Roberti M; Rossi T; Cermelli C; Portolani M; Malagoli M; Castelli M
Anticancer Drug Des; 1998 Jul; 13(5):397-406. PubMed ID: 9702206
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of substituted homoisoflavonoids on enteroviruses.
Tait S; Salvati AL; Desideri N; Fiore L
Antiviral Res; 2006 Dec; 72(3):252-5. PubMed ID: 16934879
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives.
Tonelli M; Simone M; Tasso B; Novelli F; Boido V; Sparatore F; Paglietti G; Pricl S; Giliberti G; Blois S; Ibba C; Sanna G; Loddo R; La Colla P
Bioorg Med Chem; 2010 Apr; 18(8):2937-53. PubMed ID: 20359898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
